FDA authorizes N95 decontamination system’s emergency use

The Food and Drug Administration May 27 authorized the emergency use of the Stryker Sustainability Solutions VHP N95 Respirator Decontamination System during the COVID-19 pandemic.
The device decontaminates compatible N95 respirators for multiple-user reuse to prevent exposure to pathogenic biological airborne particulates when there are insufficient supplies of face-filtering respirators. Hospitals should note that N95 respirators containing cellulose-based materials are incompatible with the SSS VHP N95 RDS and respirators are limited to a maximum of three decontaminations via the device.
Related News Articles
Headline
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee today recommended the approval of Johnson & Johnson’s COVID-…
Headline
The Substance Abuse and Mental Health Services Administration will host a March 3 roundtable discussion on the academic, social and emotional impacts of…
Headline
Due to the COVID-19 public health emergency, the Centers for Medicare & Medicaid Services will apply an automatic extreme and uncontrollable circumstances…
Headline
Israeli patients aged 70 and older were much less likely to require mechanical ventilation for COVID-19 after most people in their age group had received the…
Headline
AHA today released a one-stop web hub for hospitals and health systems to find communication resources related to COVID-19 vaccines.
The hub pulls…
Headline
The Food and Drug Administration will allow undiluted frozen vials of the Pfizer COVID-19 vaccine to be transported and stored at conventional pharmaceutical…